Display Settings:

Format
Sort by

Send to:

Choose Destination

Results: 2

1.

Antidiabetic actions of a non-agonist PPARγ ligand blocking Cdk5-mediated phosphorylation.

Choi JH, Banks AS, Kamenecka TM, Busby SA, Chalmers MJ, Kumar N, Kuruvilla DS, Shin Y, He Y, Bruning JB, Marciano DP, Cameron MD, Laznik D, Jurczak MJ, Schürer SC, Vidović D, Shulman GI, Spiegelman BM, Griffin PR.

Nature. 2011 Sep 4;477(7365):477-81. doi: 10.1038/nature10383.

PMID:
21892191
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Controlling a master switch of adipocyte development and insulin sensitivity: covalent modifications of PPARγ.

Floyd ZE, Stephens JM.

Biochim Biophys Acta. 2012 Jul;1822(7):1090-5. doi: 10.1016/j.bbadis.2012.03.014. Epub 2012 Apr 4. Review.

PMID:
22504298
[PubMed - indexed for MEDLINE]
Free PMC Article

Supplemental Content

Write to the Help Desk